Switch to:

New Drugs and Biologicals Reimbursement Policy

Switch to:
Switch to:

Search

Popular Tasks

Contact us

Neighborhood Care

New Drugs and Biologicals Reimbursement Policy

11/15/2023

Effective March 1, 2024, EmblemHealth and ConnectiCare will align with CMS on which drugs and biologics are considered routine under facility, surgical, and room and board charges and which drugs will be reimbursed separately. The plan will follow the CMS status of pass-through payments or separately reimbursed payments as detailed in our new Drugs and Biologicals Reimbursement Policy.

 

JP 63744 11/2023

Provider Update

ALSO OF INTEREST

Global Surgery Reimbursement Policy Concerning an Unplanned Return to the Operating Room; Modifier 78 will receive a 20% Fee Reduction* Preauthorization Requirement Changes Starting Jan. 1, 2024 Reimbursement Policy Updates
provider

Language Assistance:

© 2023 EmblemHealth. All Rights Reserved.

Any information provided on this Website is for informational purposes only. It is not medical advice and should not be substituted for regular consultation with your health care provider. If you have any concerns about your health, please contact your health care provider's office.

Also, this information is not intended to imply that services or treatments described in the information are covered benefits under your plan. Please refer to your Membership Agreement, Certificate of Coverage, Benefit Summary, or other plan documents for specific information about your benefits coverage.